Provided by Tiger Trade Technology Pte. Ltd.

Galectin Therapeutics

2.76
-0.0500-1.78%
Post-market: 2.760.00000.00%19:26 EST
Volume:158.31K
Turnover:435.43K
Market Cap:177.94M
PE:-4.67
High:2.81
Open:2.72
Low:2.70
Close:2.81
52wk High:7.13
52wk Low:1.12
Shares:64.47M
Float Shares:44.93M
Volume Ratio:0.49
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5905
EPS(LYR):-0.7575
ROE:-3727.94%
ROA:-87.09%
PB:-1.41
PE(LYR):-3.64

Loading ...

Jan 21, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities